| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 818-72-4 | 1-辛炔-3-醇 | 1-Octyn-3-ol; (RS)-1-Octyn-3-ol; (?à)-1-Octyn-3-ol; 1-Ethynyl-1-hexanol; 3-hydroxyoct-1-yne |  | C8H14O | 詳情 | 供應商 |
| 42578-91-6 | Coenzyme A,S-(3-hydroxyoctadecanoate) (7CI,9CI); 3-hydroxyoctadecanoyl-CoA; DL-b-Hydroxystearyl coenzyme A; b-Hydroxyoctadecanoyl-CoA; b-Hydroxystearoyl-CoA; b-Hydroxystearoyl-coenzyme A |  | C39H70N7O18P3S | 詳情 | 供應商 | |
| 160525-18-8 | Cholest-5-en-3-ol (3b)-, 3-hydroxyoctadecanoate; Cholest-5-en-3-ol(3b)-, hydroxyoctadecanoate (9CI); Cholesterol hydroxystearate; Cholesteryl hydroxystearate |  | C45H80O3 | 詳情 | 供應商 | |
| 120659-38-3 | Octanoic acid,3-hydroxy-, homopolymer; 3-hydroxyoctanoicacid homopolymer; 3-hydroxyoctanoic acid polymer; Poly(3-hydroxyoctanoic acid); Poly(b-hydroxyoctanoic acid); b-Hydroxyoctanoic acid homopolymer |  | C8H16O3 | 詳情 | 供應商 | |
| 14292-27-4 | Octanoic acid,3-hydroxy-; Caprylicacid, b-hydroxy- (4CI); (?à)-3-hydroxyoctanoic acid; 3-Hydroxycaprylic acid; 3-hydroxyoctanoic acid; b-Hydroxyoctanoic acid |  | C8H16O3 | 詳情 | 供應商 | |
| 7367-87-5 | Octanoic acid,3-hydroxy-, methyl ester; 3-hydroxyoctanoicacid-methyl-ester; Methyl 3-hydroxycaprylate; Methyl 3-hydroxyoctanoate; b-Hydroxyoctanoic acid methyl ester |  | C9H18O3 | 詳情 | 供應商 | |
| 24341-38-6 | Prostan-1-oic acid,15-hydroxy-9-oxo- (9CI); Cyclopentaneheptanoicacid, 2-(3-hydroxyoctyl)-5-oxo-, trans- (8CI); 15-Hydroxy-9-oxoprostanoic acid; AY 22093; trans-2-(3-hydroxyoctyl)-5-oxocyclopentaneheptanoic acid |  | C20H36O4 | 詳情 | 供應商 | |
| 27376-74-5 | Prost-5-en-1-oic acid,9,11,15-trihydroxy-, (5Z,9a,11a,15S)-; 5-Heptenoicacid, 7-[3,5-dihydroxy-2-(3-hydroxyoctyl)cyclopentyl]-, stereoisomer (8CI); 13,14-Dihydro-PGF2a; 13,14-Dihydrodinoprost; 13,14-Dihydroprostaglandin F2a; Dihydroprostaglandin F2a; ONO 207 |  | C20H36O5 | 詳情 | 供應商 | |
| 26892-17-1 | Prost-8(12)-en-1-oicacid, 15-hydroxy-9-oxo-, (15S)- (9CI); 1-Cyclopentene-1-heptanoicacid, 2-(3-hydroxyoctyl)-5-oxo- (8CI); PGE1-237; Prostaglandin E1-237 |  | C20H34O4 | 詳情 | 供應商 | |
| 363-22-4 | Prost-5-en-1-oic acid,11,15-dihydroxy-9-oxo-, (5Z,11a,15S)-; 5-Heptenoicacid, 7-[3-hydroxy-2-(3-hydroxyoctyl)-5-oxo-cyclopentyl]-, stereoisomer (8CI); 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxyoctyl)-5-oxocyclopentyl]- (7CI); 11a,15-Dihydroxy-9-ketoprost-5-enoicacid; 11a,15-Dihydroxy-9-oxoprost-5-enoicacid; 11a,15L-Dihydroxy-9-ketoprost-5-enoicacid; 13,14-Dihydro-PGE2; 13,14-Dihydroprostaglandin E2 |  | C20H34O5 | 詳情 | 供應商 | |
| 20592-20-5 | Prostan-1-oicacid, 9,11,15-trihydroxy-, (9a,11a,15S)-; Cyclopentaneheptanoicacid, 3,5-dihydroxy-2-(3-hydroxyoctyl)- (8CI); 13,14-Dihydro-PGF1a; Dihydro-PGF1a; Dihydroprostaglandin F1a; Prostaglandin Foa |  | C20H38O5 | 詳情 | 供應商 | |
| 177020-26-7 | Prosta-5,13-dien-1-oicacid, 9,11,15-trihydroxy-, (5Z,8b,9b,11a,13E,15S)-; 8-ISO-9BETA-PGF2ALPHA; 8-ISO PROSTAGLANDIN F2BETA; 9BETA,11ALPHA,15S-TRIHYDROXY-(8BETA)-PROSTA-5Z,13E-DIEN-1-OIC ACID; 9alpha,11alpha,15S-trihydroxy-(8beta)-prost-5Z,13E-dien-1-oic-acid; (Z)-7-[(1S,2R,3R,5R)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid; 8-isoprostaglandin PGF2beta |  | C20H34O5 | 詳情 | 供應商 | |
| 19313-28-1 | Prostan-1-oic acid,11,15-dihydroxy-9-oxo-, (11a,15S)-; Cyclopentaneheptanoicacid, 3-hydroxy-2-(3-hydroxyoctyl)-5-oxo-, stereoisomer (8CI); (15S)-Dihydroprostaglandin E1; 11,15-Dihydroxy-9-ketoprostanoic acid; 11a,15-Dihydroxy-9-oxoprostanoicacid; 13,14-Dihydro-PGE1; 13,14-Dihydroprostaglandin E1; Dihydro-PGE1; Dihydroprostaglandin E1; PGE0; U 23307; prostaglandin E0 |  | C20H36O5 | 詳情 | 供應商 | |
| 57419-49-5 | 2-Octadecanone,3-hydroxy-; 3-hydroxyoctadecane-2-one |  | C18H36O2 | 詳情 | 供應商 | |
| 73141-47-6 | 3-Hydroxysuberic acid; 3-hydroxyoctanedioicacid; Octanedioic acid,3-hydroxy-; |  | C8H14O5 | 詳情 | 供應商 | |
| 29623-28-7 | 9,11-Octadecadienoicacid, 13-hydroxy-, (9Z,11E,13S)-; 9,11-Octadecadienoicacid, 13-hydroxy-, (E,Z)-(S)- (8CI); 9,11-Octadecadienoic acid, 13-hydroxy-,[S-(E,Z)]-; (+)-Coriolic acid; (13S,9Z,11E)-13-Hydroxy-9,11-octadecadienoicacid; (9Z,11E,13S)-13-hydroxyoctadecadienoic acid; (S)-Coriolic acid; 13S-HODE; 13S-Hydroxy-9Z,11E-octadecadienoic acid; L-13-Hydroxy-cis-9,trans-11-octadecadienoic acid |  | C18H32O3 | 詳情 | 供應商 | |
| 73804-64-5 | 9,11-Octadecadienoicacid, 13-hydroxy-, (9Z,11E)-; 9,11-Octadecadienoicacid, 13-hydroxy-, (E,Z)- (8CI); (9Z,11E)-13-Hydroxy-9,11-octadecadienoic acid; (?à)-Coriolic acid; 13-HODE; 13-Hydroxy-9(Z),11(E)-Octadecadienoic acid; 13-Hydroxy-9,11-cis,trans-octadecadienoic acid; 13-Hydroxy-9-cis-11-trans-octadecadienoic acid; 13-Hydroxy-cis-9-trans-11-octadecadienoic acid; 13-Hydroxylinoleic acid; 13-hydroxyoctadeca-9,11-dienoic acid; a-Artemisolic acid |  | C18H32O3 | 詳情 | 供應商 | |
| 7367-90-0 | 3-羥基辛酸乙酯 | ethyl 3-hydroxyoctanoate; 3-Hydroxycaprylic acid ethyl ester; 3-hydroxyoctanoic acid ethyl ester |  | C10H20O3 | 詳情 | 供應商 |
| 54397-85-2 | (5Z,9Α,11RS,13E,15S)-9,11,15-三羥基血栓氧-5,13-二烯-1-烏蘇酸 | THROMBOXANE B2; THROMBOXANE B2; TXB2; 9ALPHA,11,15S-TRIHYDROXYTHROMBA-5Z,13E-DIEN-1-OIC ACID; [5Z,9ALPHA,11RS,13E,15S]-9,11,15-TRIHYDROXYTHROMBOXA-5,13-DIEN-1-OIC ACID; (5z,9α,11rs,13e,15s)-9,11,15-trihydroxythromboxa-5,13-dien-1-oic acid; (E)-7-[(2S,3S,4S)-4,6-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]oxan-3-yl]hept-5-enoic acid; TXB2, (5Z,9α,11RS,13E,15S)-9,11,15-Trihydroxythromboxa-5,13-dien-1-oic acid; (5Z,13E,15S)-9α,11,15-Trihydroxythromboxa-5,13-dien-1-oic acid |  | C20H34O6 | 詳情 | 供應商 |
| 81846-19-7 | 曲前列尼爾 | REMODULIN; REMODULIN; TREPROSTINIL; U 62840; [[(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-2-hydroxy-1-[(S)-3-hydroxyoctyl]-1H-benzo[f]indene-5-yl]oxy]acetic acid; [[[(1R)-2,3,3aβ,4,9,9aβ-Hexahydro-2α-hydroxy-1-[(S)-3-hydroxyoctyl]-1H-benz[f]inden]-5-yl]oxy]acetic acid; 15AU-81; 2-[[[(1R,2R,3aS,9aS)-2α-Hydroxy-1β-[(S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indene]-5-yl]oxy]acetic acid; UT-15 |  | C23H34O5 | 詳情 | 供應商 |